{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-021575","form_type":"8-K","ticker":"GERN","cik":"0000886744","company_name":"GERON CORP","filed_at":"2022-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.874842+00:00","generated_at":"2026-06-22T10:58:30.292490+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Geron Q3 net loss $41.1M; cash $195M; IMerge top-line results expected early Jan 2023","bullets":["Net loss of $41.1M ($0.10/share) vs $26.7M ($0.08/share) in Q3 2021; revenues $0.3M.","Cash and marketable securities $195M as of Sep 30, 2022; cash runway through mid-2024.","Top-line results from IMerge Phase 3 trial in lower risk MDS expected in early January 2023.","Class action lawsuit settlement for $24M (no admission of fault); court approval scheduled Q1 2023.","FY 2022 GAAP operating expense guidance reaffirmed at $155M-$165M; headcount 98 employees."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-021575","json":"https://secwatch.observer/filing/0000950170-22-021575.json","markdown":"https://secwatch.observer/filing/0000950170-22-021575.md","text":"https://secwatch.observer/filing/0000950170-22-021575.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/886744/000095017022021575/0000950170-22-021575-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/886744/000095017022021575/gern-20221103.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T10:58:30.292490+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c0dc575d68ad53ff7f59aa871455b9c77938fd9e","claim":"GERON CORP reported the three and nine months ended September 30, 2022 results: revenue $297,000 and $493,000, respectively, net income net loss of $41.1 million, or $0.10 per share, EPS $0.10 per share.","evidence_excerpt":"For the third quarter of 2022, the Company reported a net loss of $41.1 million, or $0.10 per share, compared to $26.7 million, or $0.08 per share, for the comparable 2021 period. Net loss for the first nine months of 2022 was $99.3 million, or $0.26 per share, compared to $84.1 million, or $0.26 per share, for the comparable 2021 period. Revenues for the three and nine months ended September 30, 2022, were $297,000 and $493,000, respectively, compared to $109,000 and $353,000 for the comparable 2021 periods.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/886744/000095017022021575/0000950170-22-021575-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three and nine months ended September 30, 2022"},{"label":"Revenue","value":"$297,000 and $493,000, respectively"},{"label":"Net income","value":"net loss of $41.1 million, or $0.10 per share"},{"label":"EPS","value":"$0.10 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}